---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-25-013380"
form_type: "8-K"
ticker: "RPRX"
cik: "0001802768"
company_name: "Royalty Pharma plc"
filed_at: "2025-04-11T23:59:59+00:00"
generated_at: "2026-05-23T16:17:28.677097+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Royalty Pharma amends purchase agreement to issue Class B shares to sellers at closing

## Summary
- Amendment No. 1 adds Royalty Pharma plc as a party to the existing Purchase Agreement.
- At closing, each seller will subscribe for Class B ordinary shares equal to the Class E shares of RPH received.
- Subscription price is nominal $0.000001 per share, paid in cash by sellers to the company.
- Amendment facilitates the transaction to acquire all equity interests of RP LLC, disclosed in January 2025.

## SEC filing metadata
- accession: 0001140361-25-013380
- form_type: 8-K
- ticker: RPRX
- cik: 0001802768
- company_name: Royalty Pharma plc
- filed_at: 2025-04-11T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1802768/000114036125013380/0001140361-25-013380-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1802768/000114036125013380/ef20047282_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-25-013380
- JSON: https://secwatch.observer/filing/0001140361-25-013380.json
- Plain text: https://secwatch.observer/filing/0001140361-25-013380.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.